We have initiated the administration of #apretude at GCMC for PrEp. This is the only injectable option for Pre Exposure Prophylaxis from HIV. Kudos to Sherry Dean, Sarah Hart and the Team at Sub Spl Clinic.
@GeisingerNE_IM
@Geisinger_IM
@GeisingerHealth
@GeisingerMedia
#prep – at Scranton, PA
Fellows Boot Camp: kudos to the pharmacy team for a great lecture on macrolides. Details on Microsoft Teams.
#investineducation
@GeisingerNE_IM @Geisinger_IM folks can reach out or DM us for link to the lectures – at Scranton, PA
July in NE USA ID Fellowship Program means two things :
New Learners
Tick Borne Illness( fever, fatigue, malaise in a gardener, t penia)
@ID_fellows
What a way to start the case conference series. Thank you Dr. Thulasie Sivarajah for the presentation. – at Pennsylvania, USA
Our first case conference with New Fellows ( Dr. Limgala and Dr. Curran).
#feelingproud . – at Pennsylvania, USA
Dr. Taesung Kwon addressing the new learners. Exciting times ahead.
@Geisinger_IM @GeisingerNE_IM
@GeisingerCwlth – at Mechanicsville, PA
Geisinger_ID retweeted
SOLIDARITY concluded “small effect against death”. Why?
SOLIDARITY RCT: Significant death reduction by #Remdesivir (vs SOC)➡️RR=0.86 (0.76-0.98)
👉Compared to another open-label trial
RECOVERY RCT: Significant death reduction by #Dexamethasone (vs SOC)➡️RR=0.82 (0.72-0.94)
2/2
👇
First patient of #cabenuva at @GeisingerHealth Community Medical Center. Thrilled about it.
Special thanks to Sarah Hart and Dr. Darrell McBride
@iamanilsingh
@GeisingerNE_IM
@Geisinger_IM
Geisinger_ID retweeted
Conscientious, compassionate, and communicative are just three words to describe Namita Sharma, M.D. Dr. Sharma was named to our 2022 Top Physicians Under 40 list. #PAMEDProud See the full list at pamedsoc.org/Top40. @GeisingerCwlth @GeisingerHealth @LackawannaCMS
Case conference: 4/20/22 by Dr. Jimenez.
What is the role for inpatient quantiferon testing toward diagnosing active TB ?
- Not much
@GeisingerNE_IM
@Geisinger_IM
What to do with indeterminate test?
- Repeat, or do a TST or do neither
- if risk is high, consider two step test
- if risk is low, do nothing
@GeisingerNE_IM
@Geisinger_IM
Common mutations for ART in HIV.
Thank you once again Dr. Mckenzie.
@amitnamita
@Geisinger_IM
@GeisingerNE_IM
@sfnaidooMD
@jtraposa
Excellent talk about HIV resistance by Dr. Paula Mckenzie. @jtraposa @infectiologue @Geisinger_IM @GeisingerNE_IM
#IMBoards.















